Cargando…

Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents

Metastatic cancer is considered a fatal progression of cancer worldwide. It has been shown that a key player in this scenario is the CXC chemokine receptor 2 (CXCR2). To identify novel CXCR2 antagonists, a pharmacophore model was built with the HipHop program by screening a database containing compo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Che, Jinxin, Wang, Zhilong, Sheng, Haichao, Huang, Feng, Dong, Xiaowu, Hu, Youhong, Xie, Xin, Hu, Yongzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society Publishing 2018
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083693/ https://www.ncbi.nlm.nih.gov/pubmed/30109074 http://dx.doi.org/10.1098/rsos.180176

Ejemplares similares

Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
por: Lagarde, Nathalie, et al.
Publicado: (2016)

Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking
por: Jafari, Fataneh, et al.
Publicado: (2018)

Bicyclo[2.2.1]heptane containing N,N′-diarylsquaramide CXCR2 selective antagonists as anti-cancer metastasis agents
por: Che, Jin-Xin, et al.
Publicado: (2018)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
por: Kutlushina, Alina, et al.
Publicado: (2018)

Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists
por: Liu, Tao, et al.
Publicado: (2013)

Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands
por: Zhou, Zhicheng, et al.
Publicado: (2023)

Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t
por: Ward, Richard J., et al.
Publicado: (2020)

Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
por: Liu, Congshan, et al.
Publicado: (2020)

Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents
por: Dhuguru, Jyothi, et al.
Publicado: (2020)

Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists
por: Mishra, Rama K., et al.
Publicado: (2016)

Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore‐based virtual screening approach
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Molecular basis for the antagonistic activity of an anti-CXCR4 antibody
por: Peng, Li, et al.
Publicado: (2015)

Discovery of CNS-Like D3R-Selective Antagonists Using 3D Pharmacophore Guided Virtual Screening
por: Lee, June Hyeong, et al.
Publicado: (2018)

Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors
por: Vuorinen, Anna, et al.
Publicado: (2014)

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019)

Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents
por: Karaküçük-İyidoğan, A., et al.
Publicado: (2019)

MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys
por: Aceto, Mario D., et al.
Publicado: (2012)

Pharmacophore-Based Discovery of Viral RNA Conformational Modulators
por: Martín-Villamil, María, et al.
Publicado: (2022)

Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using in vivo studies
por: Sharma, Mukta, et al.
Publicado: (2020)

Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore
por: Koga, Hitomi, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1,4-Di-N-oxide Derivatives as Hypoxic Selective Anti-tumor Agents
por: Hu, Yunzhen, et al.
Publicado: (2012)

PharmaGist: a webserver for ligand-based pharmacophore detection
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2008)

Design of dual ligands using excessive pharmacophore query alignment
por: Moser, Daniel, et al.
Publicado: (2012)

Flavonoids as Vasorelaxant Agents: Synthesis, Biological Evaluation and Quantitative Structure Activities Relationship (QSAR) Studies
por: Dong, Xiaowu, et al.
Publicado: (2011)

Pharmacophore-based design and discovery of (−)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis
por: Xie, Qiong, et al.
Publicado: (2017)

Discovery and Computer Aided Potency Optimization of a Novel Class of Small Molecule CXCR4 Antagonists
por: Vinader, Victoria, et al.
Publicado: (2013)

Discovery of novel dual adenosine A(1)/A(2A) receptor antagonists using deep learning, pharmacophore modeling and molecular docking
por: Wang, Mukuo, et al.
Publicado: (2021)

Water Pharmacophore: Designing Ligands using Molecular Dynamics Simulations with Water
por: Jung, Sang Won, et al.
Publicado: (2018)

The Use of Zidovudine Pharmacophore in Multi-Target-Directed Ligands for AIDS Therapy
por: Bianco, Maria da Conceição Avelino Dias, et al.
Publicado: (2022)

CXCR4 antagonists for treatment of breast cancer
por: Cortés, Javier, et al.
Publicado: (2018)

Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5
por: Fang, Xiaocui, et al.
Publicado: (2017)

Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2
por: Maeda, Dean Y., et al.
Publicado: (2014)

Discovery of YopE Inhibitors by Pharmacophore-Based Virtual Screening and Docking
por: Ozbuyukkaya, Gizem, et al.
Publicado: (2013)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
por: Pu, Yinglan, et al.
Publicado: (2017)

Discovery of Lonafarnib-Like Compounds: Pharmacophore Modeling and Molecular Dynamics Studies
por: Rampogu, Shailima, et al.
Publicado: (2020)

Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents
por: Cele, Favourite N, et al.
Publicado: (2016)

pharmACOphore: multiple flexible ligand alignment based on ant colony optimization
por: Hessler, Gerhard, et al.
Publicado: (2010)

Discovery of talmapimod analogues as polypharmacological anti-inflammatory agents
por: Liu, Wandong, et al.
Publicado: (2019)

Synthesis and Anti-HIV Activity of a Novel Series of Isoquinoline-Based CXCR4 Antagonists
por: Shad, Mastaneh Safarnejad, et al.
Publicado: (2021)

The role of CXCR3 and its ligands expression in Brucellar spondylitis
por: Hu, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_09jhot33f1v6kb525cj040btra